TrialBritish journal of cancer2011
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies.
T Eisen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this paperpooled itcites it